Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M29.3Revenue (TTM) $M0.6Net Margin (%)-4,399.1Altman Z-Score-8.2
Enterprise Value $M18.1EPS (TTM) $17.7Operating Margin %-3,935.8Piotroski F-Score4
P/E(ttm)0.1Beneish M-Score3.2Pre-tax Margin (%)-4,399.1Higher ROA y-yY
Price/Book0.410-y EBITDA Growth Rate %--Quick Ratio2.6Cash flow > EarningsY
Price/Sales3.35-y EBITDA Growth Rate %-41.9Current Ratio2.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-129.9Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-222.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M16.9ROIC % (ttm)-452.1Gross Margin Increase y-yN

Gurus Latest Trades with ETRM

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ETRM is held by these investors:



ETRM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GOLDFISCHER CARLDirector 2017-05-25Sell4,668$4.85-58.35view
GOLDFISCHER CARLDirector 2017-05-25Sell4,668$4.85-58.35view
DeLange Peter M.SVP, Ops & Bus Dev 2016-06-03Buy286$38.5-94.75view
GLADNEY DAN WCEO 2015-11-12Buy714$189-98.93view
KNUDSON MARK BChrmn, Pres & CEO 2015-11-12Buy295$168-98.8view
KNUDSON MARK BChrmn, Pres & CEO 2015-08-13Buy289$262.49-99.23view
GLADNEY DAN WCEO 2015-05-16Buy81$755.98-99.73view
FRIEDMAN CATHYDirector 2014-06-19Buy11$1784.95-99.89view
EVNIN LUKEDirector 2014-01-08Sell530$2624.93-99.92view
EVNIN LUKEDirector 2014-01-08Sell530$2624.93-99.92view

Quarterly/Annual Reports about ETRM:

News about ETRM:

Articles On GuruFocus.com
EnteroMedics Announces Presentations at ObesityWeek 2017 Oct 16 2017 
EnteroMedics Announces New Employee Inducement Option Grants Oct 12 2017 
EnteroMedics Announces Acquisition Of ReShape Medical Oct 03 2017 
EnteroMedics to Present at the Ladenburg Thalmann 2017 Healthcare Conference Sep 12 2017 
EnteroMedics Begins Post-Approval Study for the Treatment of Obesity with vBloc Therapy Sep 05 2017 
Study Concludes Vagal Nerve Blocking with EnteroMedics' vBloc Therapy is Cost-Effective Aug 28 2017 
EnteroMedics Announces First Veterans Choice Program vBloc® Implant at MedStar Health in Maryland Aug 21 2017 
EnteroMedics Announces Presentations Highlighting vBloc and Gastric Vest at IFSO Annual Conference Aug 16 2017 
EnteroMedics Announces Pricing of $20 Million Underwritten Public Offering Aug 11 2017 
EnteroMedics Announces Proposed Underwritten Public Offering Aug 10 2017 
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK